# Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population

> **NCT00328029** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 35 (estimated)

## Conditions studied

- Signs and Symptoms, Respiratory

## Interventions

- **DRUG:** busulfan
- **PROCEDURE:** respiratory function tests
- **PROCEDURE:** pharmacokinetics, done during the treatment

## Key facts

- **NCT ID:** NCT00328029
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-06
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2009-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328029, "Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00328029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*